Evidence map›Paper›PMID 35089804›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Incidence, Nature, and Consequences of Oncologists' Experiences With Sexual Harassment.

Ishwaria M Subbiah, Merry Jennifer Markham, Stephanie L Graff, Laurie B Matt-Amaral, Julia L Close, Kent A Griffith, Reshma Jagsi

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Debunking Sex and Disentangling Gender From Oncology.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Ishwaria M SubbiahDivision of Cancer Medicine, Department of Palliative, Rehabilitation, and Integrative Medicine, University of Texas MD Anderson Cancer Center, Houston, TX.ORCID 0000-0002-0758-7911
Merry Jennifer MarkhamDivision of Hematology and Oncology, University of Florida College of Medicine, Gainesville, FL.ORCID 0000-0003-3567-3494
Stephanie L GraffLifespan Cancer Institute, Rhode Island Hospital, Brown University, Providence, RI.ORCID 0000-0003-1928-1722
Laurie B Matt-AmaralDivision of Hematology/Oncology, Cleveland Clinic Akron General, Akron, OH.
Julia L CloseDivision of Hematology and Oncology, University of Florida College of Medicine, Gainesville, FL.
Kent A GriffithRogel Cancer Center and Center for Bioethics and Social Sciences in Medicine, University of Michigan, Ann Arbor, MI.ORCID 0000-0003-2598-4328
Reshma JagsiDepartment of Radiation Oncology, Rogel Cancer Center, and Center for Bioethics and Social Sciences in Medicine, University of Michigan, Ann Arbor, MI.ORCID 0000-0001-6562-1228
University of Florida · USUniversity of Michigan · USBrown University · USCleveland Clinic · USThe University of Texas MD Anderson Cancer Center · US

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI THEODORE S LAWRENCE · 1988 to 2026
$178.2M
NCI NIH HHS P30 CA046592
6 · The paper itself

Abstract

purposeThe incidence and impact of workplace sexual harassment (SH) of oncologists requires rigorous characterization.

methodsOncologists identified by ASCO's Research Survey Pool and social media outreach completed validated measures of SH (encompassing gender harassment, unwanted sexual attention, and sexual coercion) and four outcomes (mental health, job satisfaction, turnover intentions, and sense of workplace safety) over the previous year. Multivariable regression models assess the impact of SH on the four outcomes.

resultsOf 271 cisgender respondents (153 women and 118 men), 189 (70%) experienced SH in the past year alone by peers and/or superiors (80% of women

conclusionThis study using validated measures of SH to systematically characterize oncologists' workplace experience demonstrates substantial incidence of SH in the previous one year alone and its impact on men and women oncologists, informing the need for and design of effective protective and preventive measures.

Indexed as

OncologistsSexual HarassmentFemaleHumansIncidenceMaleSurveys and QuestionnairesWorkplace

Identifiers

PMID35089804
PMCPMC8987225
OpenAlexW4210319739

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.